Five Treatments for Stopping Runaway Mast Cell Inflammation Caused by Lyme, Parasites, and MoldOct 19, 2020
For people with severe allergies and swollen tissues who have been diagnosed with Lyme, mold, or parasitic infections
by Greg Lee
Have you ever washed a car with a giggly little girl? One warm day, my daughter and I got out the big sponges and soaped up the car. She did the lower half and I did the upper. Her giggly side came out when she got to rinse off the car. Small girl + hose + giggles = spray daddy! She chased me around the car laughing and spraying me from top to bottom. I’m sure I got rinsed more than the car
How is being drenched by a little kid with a hose similar to excess mast cell inflammation caused by an underlying Lyme disease, parasitic, or mold infection?
Similar to being totally soaked by a giggly little girl and a garden hose, many infections can trigger a flood of excess mast cell inflammation
Multiple infections can trigger mast cells to release a large amount of inflammatory compounds. In animal studies, Lyme disease1, parasitic helminths, nematodes, protozoa including Malaria, mold including Aspergillus fumigatus hyphae, bacterial infections including Klebsiella pneumoniae, Mycoplasma pneumoniae; Pseudomonas aeruginosa, group A streptococcal (GAS) skin infection, and E. coli peritoneal and urinary infections, Haemophilus influenzae otitis media; and polymicrobial intra-abdominal sepsis can trigger mast cells to quickly release inflammatory compounds2. In human and animal studies, viral infections including Dengue3, H1N54, Herpes5, and respiratory syncytial virus6 are also capable of triggering the release of mast cell inflammation. Mast cells are an initial line of defense against invading pathogens.
Mast cells inflammation is a normal immune system response to invading pathogens
Mast cells are white blood cells that have the ability to trigger the release of infection fighting inflammatory compounds upon invading germs. These cells are are found in most tissues of the body. Immature mast cells circulate through the blood and implant in tissues with a vascular blood supply. They are particularly concentrated in the tissues exposed to the outside environment: skin, airways and intestines, which are perfect for detecting an incoming invader. These cells are also effective at keeping many infections in check.
Mast cells may also help to suppress certain infections
In mouse experiments, mast cells mediate the expulsion of parasite worms: Trichinella spiralis and Strongyloides. Moreover, mast cell–deficient mice develop larger number of parasites and larger lesions in a Leishmania major infection7. Mast cells decrease the uptake and growth of pulmonary tularemia in macrophages in another mouse study8. Unfortunately in chronic infection patients, mast cells can be hyper-activated which results in the over-production of inflammatory compounds.
Mast cell activation syndrome (MCAS) is defined as the excess over production of mast cell inflammation
Mast cell activation syndrome has been known to produce a wide range of chronic symptoms in patients with mold exposure9, Lyme disease10, recurrent infections and low antibody levels, specifically in immunoglobulin (Ig) types IgG, IgM and IgA. Symptoms often include new infections, chronic lung disease, and inflammation and infection of the gastrointestinal tract11, Ehlers–Danlos syndrome (EDS) and postural orthostatic tachycardia syndrome (POTS)12. Different systems in the body may present with these MCAS symptoms13 including:
- Dermatological: flushing, easy bruising, either a reddish or a pale complexion, itchiness
- Cardiovascular: lightheadedness, dizziness, presyncope, syncope
- Gastrointestinal: diarrhea, cramping, intestinal discomfort, nausea, vomiting, small intestine bacterial overgrowth (SIBO)
- Swallowing, throat tightness
- Psychological & Neurological: brain fog, short term memory dysfunction, difficulty with recalling words, headaches, migraines
- Respiratory: congestion, coughing, wheezing
- Vision/Eyes: ocular discomfort, conjunctivitis
- Constitutional: general fatigue and malaise, food, drug, and chemical intolerances especially fragrances, sense of being cold all the time
- Musculoskeletal: osteoporosis and osteopenia including young patients
- Rapid weight gain, obesity, diabetes
- Anaphylaxis especially if too many inflammatory compounds are dumped suddenly into a patient’s system, difficulty breathing, itchy hives, flushing or pale skin, feeling of warmth, weak and rapid pulse, nausea, vomiting, diarrhea, dizziness and fainting
Symptoms can be caused by or worsened by triggers, which vary widely and are patient-specific. Common triggers include: alcohol, and high-histamine content foods, temperature extremes, airborne smells including perfumes or smoke, exercise or exertion, emotional stress, hormonal changes – particularly during adolescence, pregnancy and women’s menstrual cycles. These symptoms are thought to be caused be genetic issues and are therefore incurable. Since mast cells are widespread throughout the body, symptoms can also occur in virtually all organs and tissues. Moreover, symptoms can flare up from time to time, waxing and waning over years to decades14. Specific inflammatory markers have been found in MCAS patients.
Specific inflammatory compounds have been identified in mast cell activation patients
Many different inflammatory compounds can be produced and released by mast cells. These compounds have been identified as markers in patients with MCAS: Beta-Tryptase15, histamine, heparin, proteases and cytokines such as Tumor Necrosis Factor alpha (TNF-α), arachidonic acid metabolites PGD2 and LTC416, and a number of other cytokines/growth factors and chemokines including Interleukin-5 (IL-5), Interleukin-6 (IL-6), Interleukin-13 (IL-13), Interleukin-16 (IL-16), stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), nerve growth factor (NGF), basic fibroblast growth factor (bFGF) and Vascular endothelial growth factor (VEGF), as well as several C-C chemokines17. Medications can help with managing MCAS symptoms.
Medications can help with reducing inflammatory compounds from mast cell activation
There have not been any therapeutic trials of medications for MCAS. Medications that have been effective have been used in animal studies, individuals, or small group human case studies. Due to the wide variance in patient symptoms, triggers, genetic and epigenetic factors, highly individualized treatment is necessary18. Anti-allergy drugs reduced mast cell inflammation in mice19, antihistamine drugs, immunosuppresive medications, kinase inhibitors, chemotherapy drugs, and in rare cases stem cell therapy have had varying success in reducing symptoms in MCAS patients20.
What else can help you to reduce runaway inflammation caused by mast cell activation?
Here are five treatments for reducing excess mast cell inflammation
Inhibiting mast cell inflammation production may help to stop chronic MCAS. Formulating remedies into microparticles called liposomes has been effective at mediating mast cell activation21. Liposomal remedies have also been effective at reducing the production of inflammatory cytokines IL-6 and TNF-α22 in a mouse study. Liposomal remedies also have been shown to penetrate deeper into host cells23 and into pathogens24 than their non-liposomal counterparts. Fortunately, liposomal encapsulation and delivery of essential oils, herbs, and supplements may increase their penetration and effectiveness against mast cell activation syndrome inflammation.
Reducing Mast Cell Inflammation Treatment #1: Essential Oils
Lavender oil inhibits mast cell inflammation in mice and rats and TNF-α production25. A 2:1 combination of essential oils of Lavender and Thyme reduced mast cell degranulation and inflammation when applied for twenty-one days in a mouse study26. German chamomile oil was highly effective at inhibiting mast cell degranulation in a lab study27 and a rat study28. Geranium essential oil inhibited cultured mast cell degranulation in another rat study29. Not only essential oils, but also herbs have been effective at inhibiting mast cell inflammation.
Reducing Mast Cell Inflammation Treatment #2: Herbs
Compounds in salvia miltiorrhiza root, Chinese name Dan Shen, blunt mast cell degranulation in a lab study30. Sanguisorbia root, Chinese name: Di Yu, inhibited mast cell degranulation, Interferon-gamma (INF-γ) and TNF-α production in a lab study31. Houttuynia, Chinese name: Yu Xing Cao, blocked the mast cell inflammatory production of TNF-α, IL-6, IL-8 and nuclear factor kappa-B (NF-kB) in a lab experiment32. Magnolia flower, Chinese name: Xin Yi Hua, has been effective in inhibiting mast cell histamine release33. Agaricus mushroom, Chinese name: Ji Song Rong, inhibits the mast cell anaphylactic shock reaction in a rat study34. Supplements can also help with mast cell inflammation.
Reducing Mast Cell Inflammation Treatment #3: Natural supplements
Curcumin, the main compound in turmeric, inhibits the release of inflammation from mast cells35. Alpha lipoic acid decreased mast cell histamine release and the anaphylactic shock reaction in a lab study36. Quercetin has also been effective in blocking the release of mast cell histamine and inflammatory cytokines Il-8, TNF, and NF-kB37. Theanine inhibited the mast cell production of histamines, TNF-α, IL-1β, IL-6, and IL-8 secretion by suppressing NF-κB activation in a lab study38. In addition to supplements, electro-acupuncture has shown to be effective at reducing mast cell inflammation.
Reducing Mast Cell Inflammation Treatment #4: Electro-acupuncture
In one rat study, electro-acupuncture on acupoint Stomach-25 inhibited the activation of Substance-P and VIP in mast cells39. Frequency Specific Microcurrent can also help with reducing histamine and inflammatory compounds.
Reducing Mast Cell Inflammation Treatment #5: Frequency Specific Microcurrent
Frequency Specific Microcurrent uses very low level electrical currents to reduce histamines, inflammatory compounds, and bacterial, fungal and parasitic infections and toxins40. These currents are combined with a second set of frequencies to target inflamed or toxic areas. As a result, allergic symptoms and inflamed areas can be dramatically reduced. A combination of remedies and treatments can help with reducing mast cell activation symptoms.
These five treatments may help to reduce excess histamines and inflammation from mast cell activation syndrome
People with Lyme disease, mold or parasites that have allergic sensitivity due to excess histamines, way too much inflammation, and symptoms that are not improving with Lyme medications may have a condition called mast cell activation syndrome. Just like redirecting a girl to rinse the car instead of soaking her dad, remedies and treatments may help to reduce the overproduction of histamine, inflammatory cytokines and persistent symptoms of mast cell activation. Processing herbs, essential oils, and supplements into microparticle remedies, called liposomes, may help them to be more effective at reducing mast cell inflammation symptoms. Since liposomal remedies requires special knowledge and equipment, work with a Lyme / liposomal literate natural remedy practitioner to develop a customized, safe, and effective treatment plan for your condition.
1 Talkington, Jeffrey, and Steven P. Nickell. “Borrelia Burgdorferi Spirochetes Induce Mast Cell Activation and Cytokine Release.” Infection and Immunity 67, no. 3 (March 1999): 1107–15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC96436/
2 Urb, Mirjam, and Donald C. Sheppard. “The Role of Mast Cells in the Defence against Pathogens.” PLOS Pathogens 8, no. 4 (April 26, 2012): e1002619. doi:10.1371/journal.ppat.1002619.
3 Chu, Ya-Ting, Shu-Wen Wan, Robert Anderson, and Yee-Shin Lin. “Mast Cell-Macrophage Dynamics in Modulation of Dengue Virus Infection in Skin.” Immunology 146, no. 1 (September 2015): 163–72. doi:10.1111/imm.12492. https://www.ncbi.nlm.nih.gov/pubmed/26059780
4 Hu, Yanxin, Yi Jin, Deping Han, Guozhong Zhang, Shanping Cao, Jingjing Xie, Jia Xue, et al. “Mast Cell-Induced Lung Injury in Mice Infected with H5N1 Influenza Virus.” Journal of Virology 86, no. 6 (March 2012): 3347–56. doi:10.1128/JVI.06053-11.
5 Larocca, R. D. “Eosinophilic Conjunctivitis, Herpes Virus and Mast Cell Tumor of the Third Eyelid in a Cat.” Veterinary Ophthalmology 3, no. 4 (2000): 221–25. https://www.ncbi.nlm.nih.gov/pubmed/11397307
6 Shirato, Kazuya, and Fumihiro Taguchi. “Mast Cell Degranulation Is Induced by A549 Airway Epithelial Cell Infected with Respiratory Syncytial Virus.” Virology 386, no. 1 (March 30, 2009): 88–93. doi:10.1016/j.virol.2009.01.011.
7 Urb, Mirjam, and Donald C. Sheppard. “The Role of Mast Cells in the Defence against Pathogens.” PLOS Pathogens 8, no. 4 (April 26, 2012): e1002619. doi:10.1371/journal.ppat.1002619.
8 Ketavarapu, Jyothi M., Annette R. Rodriguez, Jieh-Juen Yu, Yu Cong, Ashlesh K. Murthy, Thomas G. Forsthuber, M. Neal Guentzel, Karl E. Klose, Michael T. Berton, and Bernard P. Arulanandam. “Mast Cells Inhibit Intramacrophage Francisella Tularensis
Replication via Contact and Secreted Products Including IL-4.” Proceedings of the National Academy of Sciences of the United States of America 105, no. 27 (July 8, 2008): 9313–18. doi:10.1073/pnas.0707636105.
9 Theoharides, Theoharis C., Julia M. Stewart, Erifili Hatziagelaki, and Gerasimos Kolaitis. “Brain ‘fog,’ Inflammation and Obesity: Key Aspects of Neuropsychiatric Disorders Improved by Luteolin.” Frontiers in Neuroscience 9 (July 3, 2015). doi:10.3389/fnins.2015.00225. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490655/
10 Talkington, Jeffrey, and Steven P. Nickell. “Borrelia Burgdorferi Spirochetes Induce Mast Cell Activation and Cytokine Release.” Infection and Immunity 67, no. 3 (March 1999): 1107–15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC96436/
11 “Common Variable Immunodeficiency.” Wikipedia, September 25, 2016. https://en.wikipedia.org/w/index.php title=Common_variable_immunodeficiency&oldid=741130072. https://en.wikipedia.org/…/Common_variable…
12 “Mast Cell Activation Syndrome.” Wikipedia, November 25, 2016.
13 “Mast Cell Activation Syndrome.” Wikipedia, November 25, 2016.
14 Molderings, Gerhard J, Stefan Brettner, Jürgen Homann, and Lawrence B Afrin. “Mast Cell Activation Disease: A Concise Practical Guide for Diagnostic Workup and Therapeutic Options.” Journal of Hematology & Oncology 4 (March 22, 2011): 10. doi:10.1186/1756-8722-4-10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069946/
15 Payne, V., and P. C. A. Kam. “Mast Cell Tryptase: A Review of Its Physiology and Clinical Significance.” Anaesthesia 59, no. 7 (July 2004): 695–703. doi:10.1111/j.1365- 2044.2004.03757.x. https://www.ncbi.nlm.nih.gov/pubmed/15200544
16 Akin, Cem, Peter Valent, and Dean D. Metcalfe. “Mast Cell Activation Syndrome: Proposed Diagnostic Criteria.” The Journal of Allergy and Clinical Immunology 126, no. 6 (December 2010): 1099–104.e4. doi:10.1016/j.jaci.2010.08.035.
17 Metcalfe, Dean D. “Mast Cells and Mastocytosis.” Blood 112, no. 4 (August 15, 2008): 946–56. doi:10.1182/blood-2007-11-078097.
18 Molderings, Gerhard J., Britta Haenisch, Stefan Brettner, Jürgen Homann, Markus Menzen, Franz Ludwig Dumoulin, Jens Panse, Joseph Butterfield, and Lawrence B. Afrin. “Pharmacological Treatment Options for Mast Cell Activation Disease.” Naunyn-
Schmiedeberg’s Archives of Pharmacology 389 (2016): 671–94. doi:10.1007/s00210-016-1247-1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903110/
19 Wang, Jing, and Guo-Ping Shi. “Mast Cell Stabilization: Novel Medication for Obesity and Diabetes.” Diabetes/Metabolism Research and Reviews 27, no. 8 (November 2011): 919–24. doi:10.1002/dmrr.1272.
20 Molderings, Gerhard J., Britta Haenisch, Stefan Brettner, Jürgen Homann, Markus Menzen, Franz Ludwig Dumoulin, Jens Panse, Joseph Butterfield, and Lawrence B. Afrin. “Pharmacological Treatment Options for Mast Cell Activation Disease.” Naunyn-
Schmiedeberg’s Archives of Pharmacology 389 (2016): 671–94. doi:10.1007/s00210-016-1247-1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903110/
21 Inoh, Yoshikazu, Satoshi Tadokoro, Hiroki Tanabe, Makoto Inoue, Naohide Hirashima, Mamoru Nakanishi, and Tadahide Furuno. “Inhibitory Effects of a Cationic Liposome on Allergic Reaction Mediated by Mast Cell Activation.” Biochemical
Pharmacology, 2013. https://agris.fao.org/agrissearch/
22 Thamphiwatana, Soracha, Weiwei Gao, Marygorret Obonyo, and Liangfang Zhang. “In Vivo Treatment of Helicobacter Pylori Infection with Liposomal Linolenic Acid Reduces Colonization and Ameliorates Inflammation.” Proceedings of the National Academy of Sciences of the United States of America 111, no. 49 (December 9, 2014):
23 Deno, Sho, Naohiro Takemoto, and Hiroo Iwata. “Introduction of Antioxidant-Loaded Liposomes into Endothelial Cell Surfaces through DNA Hybridization.” Bioorganic & Medicinal Chemistry 22, no. 1 (January 1, 2014): 350–57. doi:10.1016/j.bmc.2013.11.023. https://www.ncbi.nlm.nih.gov/pubmed/24345482
24 Mugabe, Clement, Majed Halwani, Ali O. Azghani, Robert M. Lafrenie, and Abdelwahab Omri. “Mechanism of Enhanced Activity of Liposome-Entrapped Aminoglycosides against Resistant Strains of Pseudomonas Aeruginosa.” Antimicrobial Agents and Chemotherapy 50, no. 6 (June 1, 2006): 2016–22. doi:10.1128/AAC.01547-
25 Kim, H. M., and S. H. Cho. “Lavender Oil Inhibits Immediate-Type Allergic Reaction in Mice and Rats.” The Journal of Pharmacy and Pharmacology 51, no. 2 (February 1999): 221–26. https://www.ncbi.nlm.nih.gov/pubmed/10217323
26 Seo, Young Mi, and Seok Hee Jeong. “[Effects of Blending Oil of Lavender and Thyme on Oxidative Stress, Immunity, and Skin Condition in Atopic Dermatitis Induced Mice].” Journal of Korean Academy of Nursing 45, no. 3 (June 2015): 367–77. doi:10.4040/jkan.2015.45.3.367.
27 Mitoshi, Mai, Isoko Kuriyama, Hiroto Nakayama, Hironari Miyazato, Keiichiro Sugimoto, Yuko Kobayashi, Tomoko Jippo, Kazuki Kanazawa, Hiromi Yoshida, and Yoshiyuki Mizushina. “Effects of Essential Oils from Herbal Plants and Citrus Fruits on DNA Polymerase Inhibitory, Cancer Cell Growth Inhibitory, Antiallergic, and Antioxidant Activities.” Journal of Agricultural and Food Chemistry 60, no. 45 (November 14, 2012): 11343–50. doi:10.1021/jf303377f. https://www.ncbi.nlm.nih.gov/pubmed/23088772
28 Miller, T., U. Wittstock, U. Lindequist, and E. Teuscher. “Effects of Some Components of the Essential Oil of Chamomile, Chamomilla Recutita, on Histamine Release from Rat Mast Cells.” Planta Medica 62, no. 1 (February 1996): 60–61. doi:10.1055/s-2006-
29 Kobayashi, Yuko, Harumi Sato, Mika Yorita, Hiroto Nakayama, Hironari Miyazato, Keiichiro Sugimoto, and Tomoko Jippo. “Inhibitory Effects of Geranium Essential Oil and Its Major Component, Citronellol, on Degranulation and Cytokine Production by Mast
Cells.” Bioscience, Biotechnology, and Biochemistry 80, no. 6 (June 2016): 1172–78. doi:10.1080/09168451.2016.1148573. https://www.ncbi.nlm.nih.gov/pubmed/26927807
30 Han, Jing-Yan, Jing-Yu Fan, Yoshinori Horie, Soichiro Miura, De-Hua Cui, Hiromasa Ishii, Toshifumi Hibi, Hiroshi Tsuneki, and Ikuko Kimura. “Ameliorating Effects of Compounds Derived from Salvia Miltiorrhiza Root Extract on Microcirculatory Disturbance and Target Organ Injury by Ischemia and Reperfusion.” Pharmacology &
Therapeutics 117, no. 2 (February 2008): 280–95.
31 Yang, Ju-Hye, Jae-Myung Yoo, Won-Kyung Cho, and Jin Yeul Ma. “Anti-Inflammatory Effects of Sanguisorbae Radix Water Extract on the Suppression of Mast Cell Degranulation and STAT-1/Jak-2 Activation in BMMCs and HaCaT Keratinocytes.” BMC
Complementary and Alternative Medicine 16 (September 6, 2016): 347. doi:10.1186/s12906-016-1317-4. https://www.ncbi.nlm.nih.gov/pubmed/27599590
32 Lee, Hee Joe, Hye-Sook Seo, Gyung-Jun Kim, Chan Yong Jeon, Jong Hyeong Park, Bo-Hyoung Jang, Sun-Ju Park, Yong-Cheol Shin, and Seong-Gyu Ko. “Houttuynia Cordata Thunb Inhibits the Production of pro-Inflammatory Cytokines through Inhibition
of the NFκB Signaling Pathway in HMC-1 Human Mast Cells.” Molecular Medicine Reports 8, no. 3 (September 2013): 731–36. doi:10.3892/mmr.2013.1585.
33 Shen, Y., E. C. K. Pang, C. C. L. Xue, Z. Z. Zhao, J. G. Lin, and C. G. Li. “Inhibitions of Mast Cell-Derived Histamine Release by Different Flos Magnoliae Species in Rat Peritoneal Mast Cells.” Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 15, no. 10 (October 2008): 808–14. doi:10.1016/j.phymed.2008.04.012. https://www.ncbi.nlm.nih.gov/pubmed/18585022
34 Choi, Yun Ho, Guang Hai Yan, Ok Hee Chai, Yung Hyun Choi, Xin Zhang, Jung Min Lim, Ji-Hyun Kim, et al. “Inhibitory Effects of Agaricus Blazei on Mast Cell-Mediated Anaphylaxis-like Reactions.” Biological & Pharmaceutical Bulletin 29, no. 7 (July 2006):
35 Kurup, Viswanath P., and Christy S. Barrios. “Immunomodulatory Effects of Curcumin in Allergy.” Molecular Nutrition & Food Research 52, no. 9 (September 2008): 1031–39. doi:10.1002/mnfr.200700293. https://www.ncbi.nlm.nih.gov/pubmed/18398870
36 Choi, Yun Ho, Ok Hee Chai, Eui-Hyeog Han, Su-Young Choi, Hyoung Tae Kim, and Chang Ho Song. “Lipoic Acid Suppresses Compound 48/80-Induced Anaphylaxis-like Reaction.” Anatomy & Cell Biology 43, no. 4 (December 2010): 317–24. doi:10.5115/acb.2010.43.4.317.
37 Weng, Zuyi, Bodi Zhang, Shahrzad Asadi, Nikolaos Sismanopoulos, Alan Butcher, Xueyan Fu, Alexandra Katsarou-Katsari, Christina Antoniou, and Theoharis C. Theoharides. “Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans.” PLOS ONE 7, no. 3 (March 28, 2012): e33805. doi:10.1371/journal.pone.0033805.
38 Kim, N. H., H. J. Jeong, and H. M. Kim. “Theanine Is a Candidate Amino Acid for Pharmacological Stabilization of Mast Cells.” Amino Acids 42, no. 5 (May 2012): 1609– 18. doi:10.1007/s00726-011-0847-9. https://www.ncbi.nlm.nih.gov/pubmed/21344174
39 Wu, Huan-Gan, Bin Jiang, En-Hua Zhou, Zheng Shi, Da-Ren Shi, Yun-Hua Cui, Suo-Tang Kou, and Hui-Rong Liu. “Regulatory Mechanism of Electroacupuncture in Irritable Bowel Syndrome: Preventing MC Activation and Decreasing SP VIP Secretion.”
Digestive Diseases and Sciences 53, no. 6 (June 2008): 1644–51. doi:10.1007/s10620-007-0062-4. https://www.ncbi.nlm.nih.gov/pubmed/17999187
40 DC, Carolyn McMakin MA. Frequency Specific Microcurrent in Pain Management, 1e. 1 Pap/Dvdr edition. Edinburgh ; New York: Churchill Livingstone, 2011.
The medical information on this site is provided as an information resource only, and is not to be used or relied on for any diagnostic or treatment purposes. This information is not intended to be patient education, does not create any patient-practitioner relationship, and should not be used as a substitute for professional diagnosis and treatment.
Please consult your health care provider, or contact the Two Frogs Healing Center for an appointment, before making any healthcare decisions or for guidance about a specific medical condition. The Two Frogs Healing Center expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. The Two Frogs Healing Center does not endorse specifically any test, treatment, or procedure mentioned on the site.
By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by the Two Frogs Healing Center. If you do not agree to the foregoing terms and conditions, you should not enter this site.
Stay connected with news and updates!
Join our mailing list to receive the latest news and updates from our team.
Don't worry, your information will not be shared.
We hate SPAM. We will never sell your information, for any reason.